↓ Skip to main content

LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin

Overview of attention for article published in Investigational New Drugs, January 2010
Altmetric Badge

Mentioned by

patent
1 patent

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
18 Mendeley
Title
LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin
Published in
Investigational New Drugs, January 2010
DOI 10.1007/s10637-010-9391-9
Pubmed ID
Authors

Jian-Jun Gao, Zu-Hua Gao, Cui-Rong Zhao, Yi Yuan, Shu-Xiang Cui, Xiao-Fan Zhang, Yan-Na Cheng, Wen-Fang Xu, Wei Tang, Xian-Jun Qu

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 28%
Student > Bachelor 2 11%
Student > Master 2 11%
Student > Doctoral Student 1 6%
Professor 1 6%
Other 4 22%
Unknown 3 17%
Readers by discipline Count As %
Agricultural and Biological Sciences 8 44%
Pharmacology, Toxicology and Pharmaceutical Science 2 11%
Biochemistry, Genetics and Molecular Biology 2 11%
Chemistry 1 6%
Unknown 5 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 February 2013.
All research outputs
#7,552,525
of 23,039,416 outputs
Outputs from Investigational New Drugs
#327
of 1,174 outputs
Outputs of similar age
#49,392
of 166,671 outputs
Outputs of similar age from Investigational New Drugs
#4
of 12 outputs
Altmetric has tracked 23,039,416 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,174 research outputs from this source. They receive a mean Attention Score of 4.7. This one is in the 43rd percentile – i.e., 43% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 166,671 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.